Kariva (Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol)- FDA

Сделал Kariva (Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol)- FDA что, мне понравилось

Reference list at the end of the article: References should be typed in alphabetical order by first author, and the entire list should skin graft after the Acknowledgments and Disclosure Statement sections.

Journal names should be abbreviated according to the Index Medicus or World List of Scientific Periodicals. In the reference list, provide up to three authors only. For references with four or more authors, use et al. Distinguish citations with the same author-year with a letter appended to the year, e. Reference list should be double-spaced with author names in upper and lower case followed by year.

Page numbers should be inclusive. References should be presented in the following style: Abbreviations Try to restrict the use of abbreviations to SI symbols and those recommended by the IUPAC. Abbreviations should be given in parentheses after their first mention in the text if the term is used more than once.

Standard units of measurement and chemical symbols of elements may be used without definition in the body of the paper.

Chemical Formulae and Mathematical EquationsWherever possible, write mathematical equations and chemical formulae on a single line. Please submit complex vakzina johnson structures as figures.

Number equations sequentially in Arabic numerals at the right margin. Conventions In general, The Journal follows the conventions of the CBE Style Manual (Council of Biology Editors, Bethesda, MD, 1983, 5th Kariva (Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol)- FDA. Follow Chemical Abstracts and its indices for chemical names.

For guidance in the use of biochemical terminology, follow the recommendation issued by the IUPAC-IUB Commission on Biochemical Nomenclature, as given in Biochemical Nomenclature and Related Documents, published by the Biochemical Society, UK.

For enzymes, use the recommended name assigned by the IUPAC-IUB Committee on Biochemical Nomenclature, 1978, as given in Enzyme Nomenclature, published by Academic Press, New York, 1980. Genotypes should be italicized; phenotypes should not be italicized. Sleepy eyes bacterial genetics nomenclature, follow Demerec et al. Submission to data banksAll sequences, clones, etc.

Papers reporting sequences must have an accession number before submission. All manuscripts must be prepared in accordance with the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (icmje. All Mary Ann Liebert, Inc. Mary Ann Liebert, Inc. Please consult The Equator Network for more information. Many journals require formatting compliance only on revision; however, unless stated, the file formatting should comply with the following requirements on submission.

The main text file, figure legends, and tables should be prepared in Microsoft Word. Some journals may accept LaTex. Please consult your individual journal instructions for guidance. If funding information is entered correctly, the publisher will deposit the funding acknowledgements from the article as part of the standard metadata to Funder Registry.

The entered information should include funder names, funder IDs (if available), and associated grant numbers. Special care should be taken when entering this information to ensure total accuracy. Funding information must also be provided within the manuscript. Authors funded by these organizations should follow the self-archiving terms and conditions of these separate agreements based on the policies of the specific funding institutions.

If you have questions, please contact us for more information. All submissions are subject to peer review after initial editorial evaluation for suitability. A minimum of two reviews are required for most journals if the manuscript proceeds to the review stage. Final decisions on the manuscript are solely inflammatory disease pelvic the discretion of the Editor(s).

Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, in the same form or substantially similar form. Conference abstracts are excluded. If work was presented at a conference, supply the Kariva (Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol)- FDA, date, and location of the meeting as a footnote on the title page of the submission.

If a third party is Kariva (Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol)- FDA the manuscript, the submitting agent designation must be used, with the identity of the submitting agent disclosed. We reserve the right to reject any manuscript that does not contain this disclosure. The authors are solely responsible for any manuscript submitted on their behalf. Editors and reviewers must maintain strict confidentiality of manuscripts during the peer-review process.

Reviewers are not permitted to contact authors directly. Authors must honor any reasonable request for materials, methods, or data necessary to reproduce or validate the research findings during peer review unless it violates the privacy or confidentiality of human research subjects. The Editor-in-Chief and Associate Editors will recuse themselves from participating in the review process of any manuscript in which there is a potential or actual competing interest. All manuscripts will be processed through plagiarism detection.

Plagiarized manuscripts will be rejected immediately. Contributors who do not meet all criteria for authorship should not be listed as authors, but they Kariva (Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol)- FDA be acknowledged in the Acknowledgments section with a Kariva (Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol)- FDA medicare medical their contribution to the work.

One author should be designated as the corresponding author who will be responsible for communication between the authors and the journal editorial office and publisher. This individual will be responsible for ensuring all authors submit copyright forms, coordinating and responding to page proofs, and managing any other necessary contact during the peer review and production processes. The submission system permits only one author to be identified as the corresponding author of record.

However, we recognize that some submissions call for more than one corresponding author to be noted. If the paper is accepted for publication, the full contact information for all designated co-authors will be listed at the end of the article as per usual journal style. Changes in authorship after submission or acceptance of a paper are generally not permitted, but the editorial leadership recognizes that in certain circumstances, it may be required.



15.01.2020 in 15:20 Mikagar:
I will refrain from comments.

16.01.2020 in 12:09 Tygolkree:
I congratulate, the excellent answer.

17.01.2020 in 14:26 Dilrajas:
It is a pity, that now I can not express - there is no free time. But I will return - I will necessarily write that I think on this question.

17.01.2020 in 15:23 Vugami:
Allow to help you?

20.01.2020 in 06:26 Akinozuru:
I think, that you are mistaken. Let's discuss. Write to me in PM, we will communicate.